{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:23:27Z","timestamp":1760707407296},"reference-count":33,"publisher":"Wiley","issue":"s8","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In the UK and across the Western world there has been a rapid increase in oesophageal adenocarcinoma, such that this cancer is now more common than squamous cell carcinoma. The 5\u2010year mortality from oesophageal adenocarcinoma is &gt;80% and therefore there has been increasing interest in the pre\u2010malignant condition Barrett's oesophagus. Barrett's oesophagus is defined by a visible columnar\u2010lined segment with histopathological evidence of a glandular epithelium, which typically contains intestinal metaplasia. Once Barrett's oesophagus is diagnosed, most centres in the UK offer endoscopic surveillance with the aim to detect early, curable lesions. Surveillance in its current form is cumbersome and expensive, and new endoscopic and molecular developments are hoped to improve the yield of such procedures. The current treatments are symptomatic control of reflux symptoms, with more definitive treatments usually reserved for patients with at least high\u2010grade dysplasia. There is interest in chemoprevention strategies, including proton\u2010pump inhibitors, cyclo\u2010oxygenase\u20102 inhibitors and aspirin, but to date none of these have proven effective. Treatment options for high\u2010grade dysplasia include surgery, endoscopic mucosal resection (in the context of a visible lesion) and photodynamic therapy. Comparative studies between various geographical regions, as the predominant histopathological subtypes of oesophageal cancer change, may give us some clues about the pathogenesis of Barrett's adenocarcinoma.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02229.x","type":"journal-article","created":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T14:32:14Z","timestamp":1101911534000},"page":"45-49","source":"Crossref","is-referenced-by-count":21,"title":["Review article: Barrett's oesophagus and associated adenocarcinoma \u2013 a UK perspective"],"prefix":"10.1111","volume":"20","author":[{"given":"R. C.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1994.01420300051007"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(02)04267-3"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7314.675"},{"key":"e_1_2_8_7_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1742-1241.1996.tb09543.x","article-title":"Heartburn, oesophagitis and Barrett's oesophagus in self\u2010medicating patients in general practice","volume":"50","author":"Corder A","year":"1996","journal-title":"Br J Clin Pract"},{"key":"e_1_2_8_8_2","first-page":"A455","article-title":"The prevalence of Barrett's oesophagus in a UK centre over 15 years","volume":"50","author":"Blankenstein MV","year":"2002","journal-title":"Gut"},{"key":"e_1_2_8_9_2","first-page":"729","article-title":"Acid sensitivity in reflux oesophagitis with or without complications","volume":"29","author":"Ball C","year":"1988","journal-title":"Gut"},{"key":"e_1_2_8_10_2","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/0016-5085(90)90607-3","article-title":"Prevalence of columnar\u2010lined (Barrett's) esophagus. Comparison of population\u2010based clinical and autopsy findings","volume":"99","author":"Cameron A","year":"1990","journal-title":"Gastroenterology"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.3.304"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34748"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024715824149"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(98)00243-3"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.534"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.2.216"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9302"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90613-0"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010678913481"},{"key":"e_1_2_8_20_2","volume-title":"Gastrointestinal Endoscopy Clinics of North America.","author":"Lightdale C","year":"2003"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00939.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(96)70214-3"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.29569"},{"key":"e_1_2_8_24_2","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti\u2010inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow DC","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34244"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600820"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(98)00091-4"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.4.486"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25111"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200210000-00002"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(99)70437-2"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2168.1997.02800.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(02)00016-9"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01140-9"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02229.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02229.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02229.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T09:37:23Z","timestamp":1695807443000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02229.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":33,"journal-issue":{"issue":"s8","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02229.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02229.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}